Join ORC International and Francesco International for a complementary live webinar addressing trends impacting Rx-to-OTC switches and consumers’ sentiment on switch products in key therapeutic areas. Key discussion points include:
Consumer Perspectives on Switches
Presented by Dr. Morris S. Whitcup, Chief Research Officer, ORC International
Findings of a new ORC International Trend Report survey detailing consumer preference for OTC switches vs generics and openness to switch products and specific brands in three therapeutic areas:
- Asthma
- Hypertension
- High cholesterol
The “Enabled” Upward Trend of Rx-to-OTC Switches
Presented by Steven Francesco, CEO of Francesco International and principal author of the new report - “The Major Global Expansion of Rx-to-OTC Switches by 2016 ©”
- Technology: The Game Changer Enabling Future Rx-to-OTC Switches Globally
- The New Enabled OTC-E™ Drugs: Therapeutic Sectors & Molecules
- Insurance / Reimbursement Changes: Expanded Treatment of Chronic Illness with OTCs
- Late Stage Product Lifecycle Management Strategic and Operational Decisions
|
